ClearView Diagnostics Inc.

ClearView Diagnostics Inc. has 1 AI-enabled medical device on the FDA list. The first decision was on December 28, 2016 and the most recent on December 28, 2016 (ClearView cCAD). Its most common review panel is Radiology (1 device).